NEW ZEALAND MEDICAL JOURNAL最新文献_第7页

Trends in obesity among 4-year-old children in New Zealand-pre- and post-COVID comparison. 新西兰 4 岁儿童肥胖趋势--COVID 前后对比。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6388

Sheetalpreet Singh, Timothy Jelleyman

{"title":"Trends in obesity among 4-year-old children in New Zealand-pre- and post-COVID comparison.","authors":"Sheetalpreet Singh, Timothy Jelleyman","doi":"10.26635/6965.6388","DOIUrl":"10.26635/6965.6388","url":null,"abstract":"Aims: We described long-term trends in obesity using preschool data from New Zealand and compared rates pre- and post-COVID by key demographic variables.Methods: Growth data from the B4 School Check (B4SC) information system for the period 1 July 2012 to 30 June 2022 were used to calculate obesity rates. The date 25 March 2020 was the threshold used to compare the rates between pre- and post-COVID periods. Obesity rate ratios for these two periods were calculated for each demographic sub-group.Results: The overall obesity rate increased by 1.8% after COVID-19. Males had higher obesity rates and a greater absolute increase (2%) in the post-COVID period. The greatest absolute increase in obesity was among Pacific peoples (4.3%), followed by Māori (2.2%). Children in most deprived areas and those in the Auckland Region had greater absolute increases of 3% and 2.5% respectively, post-COVID.Conclusion: The COVID-19 lockdown has had an immediate impact on obesity rates among 4-year-old children, especially for the Pacific population, those living in high deprivation areas and regions with longer periods of lockdown (Auckland). There are implications for public health policy and practice to support children in adopting a healthy lifestyle, especially during pandemics.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Thoracic Society of Australia and New Zealand position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults: what is new and relevant to Aotearoa New Zealand? 澳大利亚和新西兰胸科学会关于儿童、青少年和成人慢性化脓性肺病和支气管扩张症的立场声明：有哪些新内容与新西兰奥特亚罗瓦地区相关？

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.e1597

Paul Dawkins, Betty Poot, Sarah Mooney

引用次数: 0

Screening for anal cancer in New Zealand. 新西兰的肛门癌筛查。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6620

Mary Birdsall

引用次数: 0

The long COVID conundrum from a New Zealand perspective. 从新西兰的角度看 COVID 的长期难题。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6419

Angus Mackay

引用次数: 0

Te Matahouroa: a feasibility trial combining Rongoā Māori and Western medicine in a surgical outpatient setting. Te Matahouroa：在外科门诊结合毛利语和西医的可行性试验。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6417

Jonathan Koea, Glennis Mark, Donna Kerridge, Amohia Boulton

{"title":"Te Matahouroa: a feasibility trial combining Rongoā Māori and Western medicine in a surgical outpatient setting.","authors":"Jonathan Koea, Glennis Mark, Donna Kerridge, Amohia Boulton","doi":"10.26635/6965.6417","DOIUrl":"10.26635/6965.6417","url":null,"abstract":"Aim: This feasibility study was undertaken to implement and assess a Rongoā Māori (traditional Māori healing)/Western medicine collaboration model in a general surgical outpatient setting.Methods: Six patients were recruited and consulted with both a Rongoā Māori practitioner and a Western trained surgeon three times in 6 months. Appointments were an average of 45 minutes duration, patient whānau (family) were welcome and kai (food) was provided as a culturally appropriate custom. Qualitative interviews were conducted with patients, whānau and practitioners after the final appointment with practitioners. The data were thematically analysed and reviewed by the team researchers.Results: Seven themes were identified from the successful collaboration: benefits of Rongoā/medical collaboration to participants; the high value of healer/doctor relationships with participants; participants' experiences of healer/doctor collaboration; healer/doctor perceptions of the Rongoā/medical collaboration process; paying attention to the ecosystem of each participant; unanimous support for Rongoā/medical collaboration to be implemented in the health system; suggestions for Rongoā/medical collaboration improvement.Conclusions: Many challenges remain, but collaboration between Rongoā Māori healing and Western health professionals in public hospitals is not only possible, but also meets the need for patient-centred care.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Concomitant septic and crystal arthropathy: a single-centre 10-year retrospective observational study in New Zealand. 合并化脓性关节病和晶体性关节病：新西兰一项为期 10 年的单中心回顾性观察研究。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6510

Saptarshi Mukerji, Padraig Ryan, Harnah Simmonds, Jessica Buckley, Jane Birdling

{"title":"Concomitant septic and crystal arthropathy: a single-centre 10-year retrospective observational study in New Zealand.","authors":"Saptarshi Mukerji, Padraig Ryan, Harnah Simmonds, Jessica Buckley, Jane Birdling","doi":"10.26635/6965.6510","DOIUrl":"10.26635/6965.6510","url":null,"abstract":"Aim: To quantify and characterise patients with coexistent septic arthritis (SA) and crystal arthritis (CA) (SACA) in an emergency department (ED) setting.Methods: A single-centre, retrospective, 10-year observational study was conducted at a major referral centre. Patients with a positive joint aspirate for CA or SA carried out in ED, were included. The Newman criteria were utilised to define SA.Results: Of the 567 patients included in the final analysis, 427 had CA and 140 had a final diagnosis of SA. Twenty-three point six percent of patients diagnosed with SA had concomitant CA, while 7.2% of patients diagnosed with CA had concomitant SA. The greatest predisposing factors for SACA were previous history of gout, rheumatoid arthritis, being immunocompromised or having joint metalware. Synovial fluid (SF) white cell count (WCC) showed excellent predictive capability for joint infection with the area under the receiver operating characteristic curves (AUROCs) of 0.81 and 0.87 for SA and SACA respectively. The receiver operating characteristic curves (ROCs) reported a SF WCC cutoff of 32,000/mm3 allowed for 100% sensitivity and approximately 50% specificity.Conclusions: SACA remains a small but important sub-group of patients at risk of misdiagnosis of CA alone. SF WCC of 32,000/mm3 may be a better cutoff than the traditionally accepted 50,000/mm3, possibly warranting inpatient admission for investigation and management of presumed SA.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Blood pressure monitoring devices in healthcare facilities of the Manawatū-Whanganui Region. 马纳瓦图-旺格努伊地区医疗机构的血压监测设备。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6548

Kian Jones, Albert Robertson, Norman Panlilio, Ankur Gupta

引用次数: 0

A case of oesophageal foreign body migration into the thyroid gland. 一例食道异物移入甲状腺的病例。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6518

Leon Kong, James Sanders

引用次数: 0

Does iodised salt sold in New Zealand contain enough iodine? 新西兰出售的碘盐是否含有足够的碘？

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6475

Nan Xin Wang, Sheila A Skeaff, Claire Cameron, Rachael M McLean

引用次数: 0

Changes in sodium valproate dispensing in women of childbearing age with a diagnosis of borderline personality disorder in Aotearoa New Zealand. 新西兰奥特亚罗瓦地区被诊断患有边缘型人格障碍的育龄妇女中丙戊酸钠配药的变化。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-06-21 DOI: 10.26635/6965.6544

Matthew Tennant, Chris Frampton, Roger Mulder, Kate Eggleston, Ben Beaglehole

{"title":"Changes in sodium valproate dispensing in women of childbearing age with a diagnosis of borderline personality disorder in Aotearoa New Zealand.","authors":"Matthew Tennant, Chris Frampton, Roger Mulder, Kate Eggleston, Ben Beaglehole","doi":"10.26635/6965.6544","DOIUrl":"10.26635/6965.6544","url":null,"abstract":"Aims: To compare sodium valproate dispensing in women of childbearing age diagnosed with borderline personality disorder in 2014 and 2019 to discover if prescribing practices in Aotearoa New Zealand have changed in response to international recommendations.Methods: National dispensing data from the Pharmaceutical Collection were linked with diagnostic data from PRIMHD (the national mental health and addiction database) to identify people diagnosed with borderline personality disorder in Aotearoa New Zealand who were dispensed psychotropic medication. Dispensing of sodium valproate for women of childbearing age was compared between 2014 and 2019. Rates of dispensing were compared between ethnicities.Results: In 2014, 10% of women of childbearing age diagnosed with borderline personality disorder were dispensed sodium valproate. This reduced to 6% of women in 2019 (p<0.001). In 2014, there was substantial ethnic disparity with 18.1% of Māori women and 15.8% of Pacific women dispensed sodium valproate compared with 7.4% of New Zealand Europeans. This disparity reduced in 2019, with 6.4% of Māori women and 12.5% of Pacific women dispensed sodium valproate compared with 5.6% of New Zealand Europeans.Conclusions: These findings suggest that international recommendations and guidelines have been effective in changing clinical practice and reducing ethnic inequities. Given the significant risk to offspring exposed to sodium valproate, we echo warnings against off-label prescribing of sodium valproate in borderline personality disorder.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0